{HEAD ~ The present invention} provides humanized, chimeric and human anti CD74 antibodies, CD74 antibody fusion proteins, immunoconjugates, {TAIL ~ vaccines} and bispecific that bind to CD74, the major histocompatibility complex class II invariant chain, Ii, which is useful for the treatment and diagnosis of B cell disorders, such as B cell malignancies, other malignancies in which the cells are reactive with CD74, and autoimmune diseases, and methods of treatment and diagnosis 
{ HEAD ~ The present invention } provides humanized , chimeric and human anti CD74 antibodies , CD74 antibody fusion proteins , immunoconjugates , { TAIL ~ vaccines } and bispecific that bind to CD74 , the major histocompatibility complex class II invariant chain , Ii , which is useful for the treatment and diagnosis of B cell disorders , such as B cell malignancies , other malignancies in which the cells are reactive with CD74 , and autoimmune diseases , and methods of treatment and diagnosis
HEAD HEAD HEAD HEAD HEAD HEAD HEAD REL OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH TAIL TAIL TAIL TAIL TAIL OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH